3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
2
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrent Squamous Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Leukemia, T-Cell
1
Leukemia, Lymphoid
1
Glioblastoma
1
Choroid Plexus Neoplasms
1
CCND1 Gene Amplification
1
Breast Neoplasm Female
1
Breast Cancer Recurrent
1
Astrocytoma
1
Interventions
Cyclophosphamide
2
palbociclib
1
olaparib
1
fludarabine
1
durvalumab
1
binimetinib
1
atezolizumab
1
Methotrexate
1
Cisplatin
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Triple Negative Breast Neoplasms
×
palbociclib
×
Clear all
NCT04494958
2025-03-24
PALBOBIN
Fundacion Oncosur
Phase 1/2
Completed
24 enrolled
10 charts